[["patients with progressive radioactive iodine-refractory thyroid cancer", "have responded to", "targeted multikinase inhibitors"], ["targeted multikinase inhibitors", "inhibit", "angiogenesis"], ["selumetinib", "targets", "the mitogen-activated protein kinase pathway"], ["selumetinib", "shows", "limited single-agent activity"], ["limited single-agent activity", "is observed in", "patients with tumors that harbor the (V600E)BRAF mutation"]]